Combinations of ascaridole, carvacrol, and caryophyllene oxide against Leishmania

Acta Tropica

Volumn 145, Issue , 2015, Pages 31-38

  Pastor, Jacinta ^a   García, Marley ^a   Steinbauer, Silvia ^b   Setzer, William N ^c   Scull, Ramón ^d   Gille, Lars ^b   Monzote, Lianet ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c UNIVERSITY OF ALABAMA IN HUNTSVILLE   (United States)

^d UNIVERSITY OF HAVANA   (Cuba)

Author keywords

Ascaridole; BALB; C mice; Carvacrol; Caryophyllene oxide; Drug combination; Leishmania amazonensis

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ASCARIDOLE; CARVACROL; CARYOPHYLLENE OXIDE; ANTIPROTOZOAL AGENT; DRUG COMBINATION; ESSENTIAL OIL; PEROXIDE; SESQUITERPENE; TERPENE; VEGETABLE OIL;

DRUG; ESSENTIAL OIL; LEISHMANIASIS; ORGANIC COMPOUND; OXIDE; PHENOL; TERPENE; VACCINE;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CHENOPODIUM AMBROSIOIDES; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG MIXTURE; DRUG POTENCY; DRUG POTENTIATION; ELECTRON SPIN RESONANCE; FEMALE; IC50; LEISHMANIA; LEISHMANIASIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MOUSE MODEL; NONHUMAN; PROMASTIGOTE; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DOSE CALCULATION; DRUG COMBINATION; DRUG EFFECTS; LEISHMANIASIS, CUTANEOUS; PHYTOTHERAPY;

ANIMALIA; CHENOPODIUM AMBROSIOIDES; LEISHMANIA AMAZONENSIS; MUS;

ANIMALS; ANTIPROTOZOAL AGENTS; CHENOPODIUM AMBROSIOIDES; DRUG COMBINATIONS; DRUG DOSAGE CALCULATIONS; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; MONOTERPENES; OILS, VOLATILE; PEROXIDES; PHYTOTHERAPY; PLANT OILS; SESQUITERPENES;

EID: 84923620340     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2015.02.002     Document Type: Article

References (35)

1. Bamonti L., Hosoya T., Pirker K.P., Böhmdorfer S., Mazzini F., Galli F., Netscher T., Rosenau T., Gille L. Tocopheramines and tocotrienamines as antioxidants: ESR spectroscopy, rapid kinetics and DFT calculations. Bioorg. Med. Chem. 2013, 21:5039-5046.
2. Baser K.H.C. Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Curr. Pharm. Design. 2008, 14:3106-3120.
3. Brown D., Davis B.T., Halsall T.G., Hands A.R. Reactions of organic peroxides. Part I. The reaction of ascaridole with ferrous sulphate. J. Chem. Soc. 1962, 4492-4497.
4. Buettner G.R. Spin trapping: ESR parameters of spin adducts. Free Radic. Biol. Med. 1987, 3:259-303.
5. Buffet P.A., Sulahian A., Garin Y.J.F., Nassar N., Derouin F. Culture microtitration a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob. Agents Chemother. 1995, 39:2167-2168.
6. Caio T.S.E., Lima M.D., Kaplan M.A.C., Nazareth M.M., Rossi-Bergmann B. Selective effect of 2',6'-dihydroxy-4'-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis. Antimicrob. Agents Chemother. 1999, 43:1234-1241.
7. Chen M., Christensen S.B., Theander T.G., Kharazmi A. Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani. Antimicrob. Agents Chemother. 1994, 38:1339-1344.
8. Delorenzi J.C., Attias M., Gattass C.R., et al. Antileishmanial activity of an indole alkaloid from Peschiera australis. Antimicrobial. Agents Chemother. 2001, 45:1349-1354.
9. den Boer M., Argaw D., Jannin J., Alvar J. Leishmaniasis impact and treatment access. Clin. Microbiol. Infect. 2011, 17:1471-1477.
10. Desjeux P. Leishmaniasis: Current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 2004, 27:305-318.
11. Donkers R.L., Workentin M.S. Kinetics of dissociative electron transfer to ascaridole and dihydroascaridole-Model bicyclic endoperoxides of biological relevance. Chem. Eur. J. 2001, 7:4012-4020.
12. Doyle P.S., Engel J.C., Pimenta P.F.P., Da Silva P.P., Dwyer D.M. Leishmania donovani: Long-term culture of axenic amastigotes at 37C. Exp. Parasitol. 2001, 73:326-334.
13. Dutta A., Bandyopadhyay S., Mandal C., Chatterjee M. Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis. Parasitol. Int. 2005, 54:119-122.
14. Fournet A., Ferreira M.E., Rojas A., Torres S., Fuentes S., Nakayama H., et al. In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of New World cutaneous leishmaniasis caused by Leishmania amazonensis. Antimicrob. Agents. Chemother. 1996, 40:2447-2451.
15. Gagnier J.J., Boon H., Rochon P., Moher D., Barnes J., Bombardier C. Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration. J. Clin. Epidemiol. 2006, 59:1134-1149.
16. Johnson M.D., Macdougall C., Ostrosky-Zeichner L., Perfect J.R., Rex J.H. Combination antifungal therapy. Antimicrob. Agents Chemother. 2004, 48:693-715.
17. Kingston D.G.I., Newman D.J. Natural products as drug leads: An old process or the new hope for drug discovery?. IDrug 2005, 8:990-992.
18. Mishra J., Saxena A., Singh S. Chemotherapy of leishmaniasis: Past, present and future. Curr. Med. Chem. 2007, 14:1153-1169.
19. Monzote L., Almannoni S., Montalvo A.M., Scull R., Miranda M., Abreu J. Activity of essential oil from Chenopodium ambrosioides grown in Cuba against Leishmania amazonensis. Chemotheraphy 2006, 52:130-136.
20. Monzote L., García M., Pastor J., Gil L., Scull R., Maes L., Cos P., Gille L. Essential oil from Chenopodium ambrosioides and main components: Activity against Leishmania, their mitochondria and other microorganisms. Exp. Parasitol. 2013, 136:20-26.
21. Monzote L., Pastor J., Scull R., Gille L. Antileishmanial activity of essential oil from Chenopodium ambrosioides and its main components against experimental cutaneous leishmaniasis in BALB/c mice. Phytomed 2014, 21:1048-1052.
22. Monzote L., Stamberg W., Staniek K., Gille L. Toxic effects of carvacrol caryophyllene oxide, and ascaridole from essential oil of Chenopodium ambrosioides on mitochondria. Toxicol. Appl. Pharmacol. 2009, 240:337-347.
23. Mukai K., Tokunaga A., Itoh S., Kanesaki Y., Ohara K., Nagaoka S., Abe K. Structure-activity relationship of the free-radical-scavenging reaction by vitamin E (alpha-, beta-, gamma-, delta-tocopherols) and ubiquinol-10: pH dependence of the reaction rates. J. Phys. Chem. B 2007, 111:652-662.
24. Oliveira-Neto M., Schubach A., Mattos M., Goncalves S., Piemez C. Pharmacology and therapeutics intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil-Anarea of Leishmania (V.) braziliensis transmission. Internat. J. Dermatol. 1997, 36:463-468.
25. Peterson A.T., Shaw J. Lutzomyia vectors for cutaneous leishmaniasis in Southern Brazil: ecological niche models predicted geographic distributions, and climate change effects. Int. J. Parasitol. 2003, 33:919-931.
26. Pink R., Hudson A., Mouries M.A., Bendig M. Opportunities and challenges in antiparasitic drug discovery. Nat. Rev. Drug. Discov. 2005, 4:727-740.
27. Seifert K., Croft S. In vitro and in vivo interactions between miltefosine and other antileishmanial drugs. Antimicrob. Agents Chemother. 2006, 50:73-79.
28. Shioji T.T., Ueda-Nakamura T., Garcia D.C., Prado B.D., Morgado J.Á., de Souza W., et al. Antileishmanial activity of parthenolide: A sesquiterpene lactone isolated from Tanacetum parthenium. Antimicrob. Agents Chemother. 2005, 49:176-182.
29. Sladowski D., Steer S.J., Clothier R.H., Balls M. An improved MTT assay. J. Immunol. Met. 1993, 157:203-207.
30. Sundar S., Chakravarty J. Leishmaniasis: An update of current pharmacotherapy. Expert. Opin. Pharmacother. 2012, 14:53-63.
31. Tolouei S., Hasheminia S., Narimani M., Khamesipour A., Shatalebi M., Hejazi S.H. Leishmanicidal activity of films containing paromomycin and gentamicin sulfate both in vitro and in vivo. Iran. J. Parasitol. 2011, 6:60-65.
32. Türkez H., Aydin E. Investigation of cytotoxic, genotoxic and oxidative properties of carvacrol in human blood cells. Toxicol. Ind. Health. 2013, 10.1177/0748233713506771.
33. Ultee A., Bennik M.H., Moezelaar R. The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl. Environ. Microbiol. 2002, 68:1561-1568.
34. World Health Organization. Leishmaniasis Available from: Accessed January 16, 2010. http://www.who.int/leishmaniasis/en/.
35. Zhao L., Guillaume L., Au J. Evaluation of combination chemotherapy: Integration of nonlinear regression curve shift, isobologram, and combination index analyses. Clin. Cancer. Res. 2004, 10:7994-8004.